Universal Health Services

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. May 21, 2026

   Departure and Compensatory Arrangements of a Certain Officer (b) On May 18, 2026, Matthew J. Peterson, Executive Vice President of the Company and President, Behavioral Health, who has been with the Company since 2019, submitted his resignation from his position with the Company, effective June 19, 2026 (“Effective Date”). Mr. Peterson intends to pursue an external career opportunity that is not competitive to the Company. (e) As a result of such resignation, all of Mr. Peterson’s unvested stock options, restricted stock units and performance based restricted stock units will terminate as of the Effective Date. Mr.

   Read the 8-K filing
2. Mar 30, 2026

   2026 Annual Incentive Bonus Performance Goals On March 26, 2026, the Compensation Committee of the Board of Directors (the “Committee”) approved specific bonus formulae for the determination of annual incentive compensation for the Company’s executive officers for the year ending December 31, 2026, pursuant to the 2022 Executive Incentive Plan which was adopted by the Committee in March, 2022 (the “Plan”). Under the formulae approved by the Committee, each of the Company’s executive officers was assigned a percentage of such executive officer’s 2026 base salary as a target bonus based upon corporate performance criteria. The corporate performance criteria target bonus award indicated below for Mr. Marc D. Miller is stipulated in his employment agreement. Mr. Alan B.

   Read the 8-K filing
3. Dec 31, 2025

   Amended and Restatement Employment Agreement of Mr. Marc D. Miller On December 30, 2025, the Compensation Committee of the Board of Directors of Universal Health Services, Inc. (the “Company”) approved amendments to the existing employment agreement between Mr. Marc D. Miller, the Company’s Chief Executive Officer (“CEO”) and President, and UHS of Delaware, a wholly owned subsidiary of the Company and, the employer of record for the Company’s management employees. The obligations of UHS of Delaware under the amended and restated employment agreement (the “A&R Employment Agreement”) are, other than as set forth herein, substantially the same as the existing employment agreement and are guaranteed by the Company. The Compensation Committee also approved an amendment to the Company guaranty to make certain conforming changes. Pursuant to the terms of the A&R Employment Agreement, Mr.

   Read the 8-K filing
4. Mar 20, 2025

   2025 Annual Incentive Bonus Performance Goals On March 19, 2025, the Compensation Committee of the Board of Directors (the “Committee”) approved specific bonus formulae for the determination of annual incentive compensation for the Company’s executive officers, pursuant to the 2022 Executive Incentive Plan which was adopted by the Committee on March 23, 2022 (the “Plan”), for the year ending December 31, 2025. Under the formulae approved by the Committee, each of the Company’s executive officers was assigned a percentage of such executive officer’s 2025 base salary as a target bonus based upon corporate performance criteria. The corporate performance criteria target bonus award indicated below for Mr. Marc D. Miller is stipulated in his employment agreement. Mr. Alan B.

   Read the 8-K filing
5. Mar 25, 2024

   2024 Annual Incentive Bonus Performance Goals On March 21, 2024, the Compensation Committee of the Board of Directors (the “Committee”) approved specific bonus formulae for the determination of annual incentive compensation for the Company’s executive officers, pursuant to the 2022 Executive Incentive Plan which was adopted by the Committee on March 23, 2022 (the “Plan”), for the year ending December 31, 2024. Under the formulae approved by the Committee, each of the Company’s executive officers was assigned a percentage of such executive officer’s 2024 base salary as a target bonus based upon corporate performance criteria. The corporate performance criteria target bonus award indicated below for Mr. Marc D. Miller is stipulated in his employment agreement dated December 23, 2020, as amended on March 23, 2022. Mr. Alan B.

   Read the 8-K filing
6. Mar 24, 2023

   (b) Lawrence S. Gibbs, a member of the Board of Directors (“Board”) of Universal Health Services, Inc. (“UHS”), has informed the Board that he has accepted a new employment opportunity which will restrict his ability to serve on UHS’ Board. Therefore, Mr. Gibbs has decided to resign from the Board effective as of March 31, 2023 and accordingly not stand for reelection at UHS’ 2023 Annual Meeting of Stockholders to be held on May 17, 2023. Mr. Gibbs’ decision to resign is not due to any disagreement with UHS, its management, or the Board on any matter relating to UHS’ operations, policies or practices. As a result of Mr. Gibbs’ resignation, UHS’ Board will be fixed at seven members. Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

   Read the 8-K filing
7. Mar 17, 2023

   2023 Annual Incentive Bonus Performance Goals On March 15, 2023, the Compensation Committee of the Board of Directors (the “Committee”) approved specific bonus formulae for the determination of annual incentive compensation for the Company’s executive officers pursuant to the 2022 Executive Incentive Plan which was adopted by the Committee on March 23, 2022 (the “Plan”) for the year ending December 31, 2023. Under the formulae approved by the Committee, each of the Company’s executive officers was assigned a percentage of such executive officer’s 2023 base salary as a target bonus based upon corporate performance criteria. The corporate performance criteria target bonus award indicated below for Mr. Marc D. Miller is stipulated in his employment agreement dated December 23, 2020, as amended on March 23, 2022. Mr. Alan B.

   Read the 8-K filing
8. Dec 7, 2022

   Departure and Compensatory Arrangements of a Certain Officer (b) (e) As previously disclosed on Form 8-K as filed on October 25, 2022, on October 22, 2022, Marvin G. Pember, Executive Vice President of the Company and President, Acute Care, who has been with the Company since 2011, informed us of his intention to retire from his position after a transition period following the commencement of employment of Edward H. Sim, the newly appointed Executive Vice President of the Company and President, Acute Care, whose employment commenced on December 5, 2022. On December 4, 2022, the Company and Marvin G. Pember (“Executive”) entered into a Separation Agreement and General Release (“Agreement”) effective as of December 31, 2022 (“Effective Date”).

   Read the 8-K filing
9. Oct 25, 2022

   Departure and Compensatory Arrangements of a Certain Officer (b) (e) On October 21, 2022, Marvin G. Pember , Executive Vice President of the Company and President, Acute Care, who has been with the Company since 2011, informed us of his intention to retire from his position after a transition period following the commencement of employment of Edward H. Sim, as described below. A compensatory arrangement with Mr. Pember is currently being discussed.

   Read the 8-K filing
10. Sep 22, 2022

    (d) Election of new Director On September 21, 2022, the Board of Directors of the Company appointed Nina Chen-Langenmayr to serve as a Class III Director of the Company. Ms. Chen-Langenmayr’s term commenced immediately and is scheduled to expire at the 2023 Annual Meeting of Stockholders to be held in May 2023. The Board upon recommendation of the Nominating and Governance Committee also indicated that it would nominate Ms. Chen-Langenmayr for election by the Company’s Class B and D stockholders at the 2023 Annual Meeting of Stockholders. Ms. Chen-Langenmayr’s compensation for her services will be consistent with the standard compensation paid to other non-employee directors of the Company, as described in the Company’s most recent proxy statement filed with the Securities and Exchange Commission on April 7, 2022.

    Read the 8-K filing
11. Mar 28, 2022

    Summary of Changes Implemented in 2022 to Executive Officer Compensation On March 23, 2022, our Compensation Committee of the Board of Directors (the “Compensation Committee”) approved changes to various elements of compensation for our Chief Executive Officer (“CEO”) and certain of our other named executive officers (“NEOs”). Below is a general summary of those changes, as compared to 2021: • Decrease in the weighting of long-term incentives (“LTI”), with accompanying increase in weighting of cash incentives. • No significant changes in target compensation levels (i.e., changes generally consist of shifts in mix of pay, not pay amounts). • Continued commitment to significant at-risk, performance-based CEO and NEO compensation programs.

    Read the 8-K filing
12. Mar 19, 2021

    (e) 2021 Annual Incentive Bonus Performance Goals On March 17, 2021, the Compensation Committee of the Board of Directors of Universal Health Services, Inc. (the “Committee”) approved specific bonus formulae for the determination of annual incentive compensation for the Company’s executive officers pursuant to the Executive Incentive Plan (the “Plan”) for the year ending December 31, 2021. Under the formulae approved by the Committee, each of the Company’s executive officers was assigned a percentage of such executive officer’s 2021 base salary as a target bonus based upon corporate performance criteria. The corporate performance criteria target bonus award indicated below for Mr. Marc D. Miller is stipulated in his employment agreement dated December 23, 2020 and effective on January 1, 2021. Mr. Alan B.

    Read the 8-K filing
13. Dec 28, 2020

    As previously announced, the Board of Directors of Universal Health Services, Inc. (the “Company”) has appointed Marc D. Miller, currently President of the Company, to assume the role of Chief Executive Officer while continuing to serve as President and a member of the Board of Directors and Alan B. Miller as Executive Chairman of the Board, in each case effective on January 1, 2021. Marc D. Miller Chief Executive Officer Employment Agreement On December 23, 2020, the Company and Marc D. Miller entered into an employment agreement (“MDM Employment Agreement”). The MDM Employment Agreement provides for the employment of Mr.

    Read the 8-K filing
14. Sep 8, 2020

    Mr. Alan B. Miller, the Chairman and Chief Executive Officer of Universal Health Services, Inc. (the “Company”) has informed the Board of Directors of the Company of his decision to step down from the role of Chief Executive Officer of the Company effective January 1, 2021. The Board of Directors has appointed Marc D. Miller, currently President of the Company, to assume the role of Chief Executive Officer while continuing to serve as President and a member of the Board of Directors and appointed Alan B. Miller as Executive Chairman of the Board effective on that date. Biographical and certain other information for each of Messrs. Alan B. Miller and Marc D. Miller (including certain transactions since the beginning of the Company’s last fiscal year in which the Company was a participant and in which each of Messrs. Alan B. Miller and Marc D.

    Read the 8-K filing
15. Jun 4, 2020

    Executive Officer Salary Reductions in Response to COVID-19 Pandemic: On June 1, 2020, in response to the COVID19 pandemic, the Compensation Committee of the Board of Directors of Universal Health Services, Inc. (the “Company”) approved the following reductions to the base salaries of the Executive Officers of the Company: (i) Mr. Alan B. Miller’s base salary will be reduced by 100% for the two-month period from June 1, 2020 through July 31, 2020, and; (ii) the base salaries for Messrs. Marc D. Miller, Steve G. Filton, Marvin G. Pember and Matthew J. Peterson will be reduced by 20% for the three-month period from June 1, 2020 through August 31, 2020.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.